1891 results about "Quinoline" patented technology

To provide a cation-dyeable polyester fiber structure, a production method of the same, and a uniform for medical use.SOLUTION: A cation-dyeable polyester fiber structure includes a cationic dye, a quinoline compound, and an ultraviolet absorber, where 0.03 mass% or more and 0.80 mass% or less of the quinoline compound is included to a mass of the cation-dyeable polyester fiber structure, a color difference ΔE between before and after irradiating the cation-dyeable polyester fiber structure with ultraviolet carbon arc lamplight is 2.0 or lower, and an antibacterial activity value A50 after 50 times of high temperature acceleration washing is larger than a standard cloth growth value F in an antibacterial evaluation method described in an SEK mark textile product certification standard.SELECTED DRAWING: None

The invention discloses a functional fracturing fluid directly prepared from flow-back fluid of complex water quality. The fracturing fluid is prepared by directly adding a salt-tolerant polymer and an ion trapping agent into the flow-back fluid. The addition amount of the salt-tolerant polymer accounts for 0.15-0.3% of the total mass of the fracturing fluid, and the addition amount of the ion trapping agent is 100-500ppm. The salt-tolerant polymer is prepared by copolymerization of acrylamide, a salt-tolerant monomer and an allyl quinoline monomer, and the molecular weight of the polymer is 4-15 million. The salt-tolerant monomer is acrylamide polyoxyethylene sodium benzenesulfonate or acrylamide sodium sulfonate. The ion trapping agent is prepared from amino trimethylene phosphonic acid, diethylene triamine penta (methylene phosphonic acid), ethylene glycol bis (2-aminoethyl ether) tetraacetic acid, p-methylphenyl diethanol amine, 2, 3-epoxypropyl trimethyl ammonium chloride, fatty alcohol-polyoxyethylene ether, citric acid and tetrahydrofurfuryl acrylate. The fracturing fluid can be directly prepared from the flow-back fluid, the flow-back fluid does not need to be pretreated, and repeated utilization of the fracturing flow-back fluid is achieved.

The present invention relates to tetrahydrobenzo-isoquinoline sulfonamides derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use in treating disorders caused by IgE (such as allergic responses, non-allergic mast cell responses or certain autoimmune responses), and in particular disorders caused by the interaction of IgE with the FIERI receptor.

The invention provides a method for preparing a sodium-storage hard carbon negative electrode material from heavy oil, which comprises the following steps: by taking the heavy oil as a raw material, doping 1wt%-5wt% of an acidic catalyst and an aldehyde crosslinking agent, and putting the mixture into a corrosion-resistant reaction kettle for shallow crosslinking polycondensation treatment; then carrying out air oxidation crosslinking to obtain an isotropic asphalt product with good fluidity and low quinoline insoluble content; and carrying out carbonization and acid-base etching treatment to prepare the sodium-storage hard carbon negative electrode material with excellent rate capability and long-period stability. According to the method, the utilization rate of small molecules in the ethylene tar is guaranteed through shallow cross-linking polycondensation by adding the acid catalyst and the aldehyde cross-linking agent, and the yield of the material is remarkably improved; and treating a cross-linked polycondensation product by using an oxidation cross-linking process to prepare the high-carbon-residue isotropic asphalt with different softening points and low quinoline insoluble content. On the basis of the process, a carbonization-acid-alkali etching process is utilized to treat isotropic asphalt, and the sodium storage hard carbon negative electrode material with high battery capacity, excellent rate capability and long-period stability is prepared.

The present invention belongs to the technical field of drug synthesis, relating to the synthesis of drugs for the prevention or treatment of diseases such as Alzheimer's disease and Parkinson's disease. Specifically, it relates to pharmaceutical intermediates and synthesis methods and isoquinoline derivatives and synthesis methods therefor. The pharmaceutical intermediate has a chemical structure shown in Formula II, wherein X is a halogen, and R is an amino protecting group. The synthesis of the pharmaceutical intermediate is simple, operates under mild conditions, and results in a high yield. Additionally, the pharmaceutical intermediate can be used to prepare isoquinoline derivatives.

The invention belongs to the technical field of organic electroluminescent materials, and provides an iridium-containing heterocyclic phosphorescent doping material and an organic electroluminescent device.The doping material has a compound general formula shown in the formula I. Quinoline and a naphthalene ring are connected through silane or germane, and a silicon or germanium six-membered heterocyclic structure is formed. And reacting with iridium metal and a diketone monomer to obtain the iridium metal heterocyclic phosphorescent organic light-emitting material. The heteroatom silicon or germanium in the material can adjust molecular orbital HOMO and LUMO energy levels, and the polarity effect of heteroatoms promotes electron migration, reduces interface potential barriers and electron injection barriers, reduces carrier injection loss and improves carrier mobility, so that driving voltage is reduced, and the external quantum efficiency of a device is improved. In addition, the silicon or germanium heterocyclic ring has better rigidity, so that the overall stability of the structure is enhanced, and the rigid structure can prolong the service life of the device.

The invention discloses an endogenous anti-aging composition based on an internal and external synergistic mechanism and a preparation method of the endogenous anti-aging composition. The endogenous anti-aging composition based on the internal and external synergistic mechanism is prepared from the following components in parts by mass: 100 to 200 parts of alpha-ketoglutarate calcium; 100 to 200 parts of an olive leaf extract; 10 to 20 parts of nicotinic acid; 10 to 20 parts of pyrroloquinoline quinone; 20 to 60 parts of pomegranate extract; and 10 to 30 parts of coenzyme Q10. The composition and the preparation method thereof have the beneficial effects that the composition capable of integrally improving the aging state of women from multiple dimensions and the preparation method of the composition are provided.

The invention belongs to the technical field of sleep-aiding oral liquids, and discloses a sleep-aiding nerve-calming oral liquid and a preparation process thereof, the oral liquid is composed of the following components: a plant fermentation broth, fructo-oligosaccharide, gamma-aminobutyric acid, casein hydrolysis peptide, a saussurea involucrata culture, and pyrroloquinoline quinone disodium salt; wherein the plant fermentation liquor is prepared from spina date seeds, poria cocos, lilies, Chinese dates, lotus seeds, lophatherum gracile, seville orange flowers, red roses with double petals, roselle, wheat, licorice roots, peach kernels, sweet-scented osmanthus and plant lactobacillus BXM2. The core component spina date seed saponin A is combined with gamma-aminobutyric acid to directly regulate the GABAergic nervous system, shorten the sleep latency and effectively help sleep and tranquilize the nerves; casein hydrolysis peptide promotes secretion of melatonin, and cooperates with the saussurea involucrata culture to resist oxidative stress, improve the sleep structure and restore circadian rhythm; small molecular active peptides and flavonoid glycosides are generated through fermentation, and anxiety mood, fatigue state and qi and blood circulation are improved; nano embedding and targeted delivery technologies are adopted in the whole process, the bioavailability is high, and the risk of drug dependence is avoided.

The present application relates to the technical field of small molecule drugs, in particular to a isoquinoline drug and its application in improving or treating digestive tract tumors, and aims to provide a compound, a pharmaceutical composition containing the compound and its application in treating colorectal cancer and gastric cancer, and provides a 3,13-position substituted berberine derivative, the drug itself has less toxicity and does not affect the growth of normal human cells, and has a good application prospect in the development of novel antitumor drugs, especially in the development of anti-digestive tract tumor drugs.

To provide a pharmaceutical composition comprising a novel compound which has a thyroid-stimulating hormone receptor antagonist activity and is useful for the treatment of thyroid-related diseases.SOLUTION: There is provided a pharmaceutical composition comprising a 3,4-dihydroquinolin-2(1H)-one compound represented by a formula (I) or a pharmacologically acceptable salt thereof. A pharmaceutical composition comprising the compound or the pharmacologically acceptable salt thereof has an antagonist activity against thyroid-stimulating hormone receptors and is useful as a therapeutic agent or the like for thyroid-related diseases (for example, hyperthyroidism, Graves' disease, thyroid eye disease and thyroid cancer).SELECTED DRAWING: None

The invention belongs to the field of alkyd resin, and particularly relates to alkyd resin with high adhesive force and a preparation method thereof. The high-adhesion alkyd resin is prepared from soya oil acid, a nitrogen-containing heterocyclic compound, phthalic anhydride, pentaerythritol and hydroxyl-terminated polydimethylsiloxane. By introducing a nitrogen-containing heterocyclic compound (such as quinoline and triazole) and hydroxyl-terminated polydimethylsiloxane (PDMS), the molecular structure of the alkyd resin is remarkably optimized, so that the alkyd resin is superior to the traditional alkyd resin in the aspects of heat resistance, corrosion resistance, mechanical strength, adhesive force, construction performance and the like. The coating is suitable for the fields of high-temperature anticorrosive coatings, marine coatings, industrial protective coatings and the like, and shows remarkable technical advantages and wide market prospects.

The present invention provides a fiber structure having excellent antibacterial properties and washing durability, and a method for producing the same. [Solution] A textile structure having polyamide fibers and containing a dye, a quinoline-based compound, and a phenol derivative, wherein the textile structure contains 0.04% by mass or more of the quinoline-based compound relative to the mass of the textile structure, and even after 10 standard washes in accordance with the "SEK Mark Textile Product Washing Method," the textile structure contains 0.04% by mass or more of the quinoline-based compound relative to the mass of the textile structure, and 0.20% by mass or more and 4.00% by mass or less of the phenol derivative relative to the mass of the textile structure.

The invention discloses a high-whiteness EVA chemical foaming sole material and a preparation method thereof, and belongs to the technical field of footwear products. The EVA chemical foaming sole material is formed by chemical foaming of an EVA composite raw material. The EVA composite raw materials mainly comprise 50 to 70 parts of EVA, 20 to 40 parts of an olefin thermoplastic elastomer, 0.4 to 0.7 part of a peroxide cross-linking agent, 2 to 4 parts of an AC foaming agent, 1 to 2 parts of zinc oxide, 0.3 to 0.8 part of 6-hydroxy-1, 2, 3, 4-tetrahydroquinoline, 0.5 to 1 part of nano zinc carbonate and 0.5 to 1 part of pentaerythritol tetrastearate. The whitening effect of the sole material can be realized on the premise of protecting the EVA foaming-crosslinking structure; therefore, the attractiveness of the product is improved, the durability is better, the mechanical properties and other properties of the EVA foamed sole are not influenced, and the high-quality requirements of elasticity, pressure resistance, comfort and the like of sports shoes can be met.

The invention provides a quinolinyl ketone compound as well as a preparation method and application thereof, and belongs to the technical field of compounds containing two or more heterocyclic rings. The quinolinyl ketone compound can be obtained by taking enaminone, a perfluoroalkane compound and aminobenzene as raw materials, adding an organic solvent and alkali and stirring and reacting in an argon atmosphere and under blue light irradiation. The prepared product has good antibacterial activity, the preparation condition is mild, and the yield is basically kept at 80% or above and can reach 90% to the maximum.

The invention belongs to the technical field of health-care food, and particularly relates to a composition and oral drops with the effects of dispelling the effects of alcohol, protecting the liver and relieving hangover as well as a preparation method and application of the composition and the oral drops. The invention provides a composition taking silybin eutectic crystal, curcumin eutectic crystal, ampelopsis grossedentata extract, pyrroloquinoline quinone disodium salt, reduced glutathione, alpha-ketoglutaric acid, vitamin, hericium erinaceus extract, frankincense extract, licorice extract and the like as main active ingredients, and the composition is subjected to scientific formula screening and functional verification, and has the advantages that the composition has the obvious curative effect, and the curative effect is obvious; the traditional Chinese medicine composition can effectively improve the metabolism of ethanol, protect liver and gastric mucosa, and is helpful for relieving hangover-related symptoms such as fatigue, thirst, sleepiness, headache, dry mouth, stomachache, nausea, hypomnesis, inattention and the like.

The present application provides a pharmaceutical combination of a quinoline derivative and an antibody, which comprises an immune checkpoint inhibitor and a tyrosine kinase inhibitor, wherein the tyrosine kinase inhibitor is a compound of formula I or a pharmaceutically acceptable salt thereof. The pharmaceutical combination in the present application shows good anti-lung tumor and anti-liver tumor activities.

The invention discloses a modified thermoplastic solid-solution anticorrosive coating, a preparation method thereof and application of the modified thermoplastic solid-solution anticorrosive coating on the surface of a pneumatic actuator, and belongs to the field of industrial equipment surface protection materials. Two novel modifiers are designed to construct a multi-protection system. Wherein the layered double hydroxide-silane covalent grafting modifier takes magnesium-aluminum layered double hydroxide as a matrix, and after covalent modification by a silane coupling agent, the matrix is compounded with a quinoline derivative in an intercalation manner, so that the interface bonding and barrier properties are improved; according to the polyaniline-graphene covalent grafting modifier, few layers of graphene and polyaniline are copolymerized and then grafted with a polyurethane prepolymer, so that the toughness and the conductive corrosion resistance of a coating are enhanced. The coating is prepared by taking polyethersulfone as a matrix, compounding the modifier, nano silicon dioxide and other components, mixing, dissolving, dispersing at a high speed and ultrasonically defoaming. The coating has the advantages of high interface adhesion, strong corrosion resistance, dynamic fatigue resistance, environmental protection, no solvent and the like, and is suitable for surface protection of key components such as a pneumatic actuator shell.

The invention discloses an application of paenibacillus polymyxa in improving the yield of pyrroloquinoline quinone, and relates to an application of hyphomicrobium in improving the nitrogen fixation capability of the paenibacillus polymyxa. The invention also discloses a co-culture system with high pyrroloquinoline quinone yield. The invention further discloses the hyphomicrobium, and the preservation number of the hyphomicrobium is CCTCC (China Center For Type Culture Collection) NO: M 20241604. The invention further discloses the paenibacillus polymyxa, and the preservation number of the paenibacillus polymyxa is CCTCC (China Center for Type Culture Collection) NO: M 20241603. The invention also discloses a fermentation broth prepared by using the co-culture system. The invention further discloses application of the co-culture system and the fermentation liquor. The paenibacillus polymyxa and the hyphomicrobe are co-cultured and fermented, so that the yield of PQQ produced by the hyphomicrobe can be bidirectionally promoted at the same time, and the nitrogenase activity of the paenibacillus polymyxa can be improved; the co-culture fermentation broth can improve nitrogen fixation, stress resistance, growth and yield of crops.

The application relates to the technical field of silver powder preparation, and discloses a method for producing silver powder by using photovoltaic panel battery pieces, which comprises the following steps: S1, after waste photovoltaic battery pieces and acid liquor are initially mixed, a leaching agent is added for secondary mixing, and filtration is carried out to obtain a silver-containing liquid; S2, sodium chloride is added into the silver-containing liquid to obtain a precipitate; and S3, the precipitate is subjected to reduction treatment to obtain silver powder; and the components of the leaching agent include 8-hydroxyquinoline and / or pyridine-2,6-dicarboxylic acid. Through the technical scheme, the problem of low silver powder yield in the production of silver powder by using photovoltaic battery pieces in the related art is solved.

The invention discloses a mercury ion detection fluorescent probe based on quinoline as well as a preparation method and application of the mercury ion detection fluorescent probe. The fluorescent probe and a structural formula of the fluorescent probe are shown as a formula I in the specification. A quinoline derivative, namely 2-methyl-7-hydroxyquinoline, is used as a fluorescent chromophore, a thioester group is used as a recognition group, and the prepared fluorescent probe shows high sensitivity and high selectivity on Hg < 2 + > in a solution. The preparation method of the fluorescent probe is simple in steps, raw materials are easy to obtain, and the obtained product is a white flocculent solid, is easy to store, has a wide application prospect and can be produced and applied on a large scale.

The invention provides an anti-aging composition and application thereof, the composition at least contains pyrroloquinoline quinone disodium salt, ergothioneine and 5-aminolevulinic acid or salt thereof in physiologically acceptable media, the composition contains PQQ, ergothioneine and 5-aminolevulinic acid (5-ALA) or salt thereof, the three components are compounded to achieve a synergistic effect, and the anti-aging effect is achieved. The dyeing intensity of beta-galactosidase is reduced, and the anti-aging effect is achieved.

The disclosure relates to a particulate composition comprising ensifentrine, wherein the particulate composition further comprises: from greater than 0.00 wt % to 0.60 wt % of 1,3-bis(2-(2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6, 1-a]isoquinolin-3(4H)-yl)ethyl)urea (BMIQU) relative to the total weight of ensifentrine; and from 0.00 wt % to 0.50 wt % of a biuret impurity of formula (A) relative to the total weight of ensifentrine. Further disclosed herein are liquid pharmaceutical compositions comprising the particulate composition, and a process 10 for producing the particulate composition are also described.

The present invention relates to compounds of formula (I), in particular their use as degradation agents for the human papilloma virus E7 protein: # imgabs0 #

The invention provides a composition for delaying senescence by activating telomerase activity. The composition is prepared from the following raw materials in parts by weight: 12.5 parts of wheat germ concentrated powder, 0.25 to 5 parts of ergothioneine, 0.25 to 5 parts of pyrroloquinoline quinone disodium salt and 0.25 to 5 parts of alpha-ketoglutaric acid. The invention further provides a preparation method and application of the composition for delaying senescence by activating telomerase activity. Through the synergistic effect of the ergothioneine and the pyrroloquinoline quinone disodium salt, the telomerase activity can be activated, the telomerase expression can be improved, the telomere length can be maintained, and the effect of delaying senescence can be achieved, so that the functional metabolism of a human body can be promoted, and the health state of the body can be improved; through the synergistic effect of the wheat germ concentrated powder and alpha-ketoglutaric acid, cell aging can be delayed; through the multi-target synergistic effect of'telomerase activation + mitochondrial repair + autophagy enhancement ', the anti-aging effect is delayed, the metabolic capability is high, the anti-aging effect is good, and safety and high efficiency are achieved; belongs to the technical field of food and health care product processing.

The invention provides a fermented beverage capable of relieving fatigue and a preparation method of the fermented beverage, and relates to the technical field of functional beverages, and the IPC classification number belongs to A23L2. The fermented beverage is prepared from a radix astragali fermentation extract, a radix platycodonis extract, L-arginine, taurine, inositol, caffeine, nicotinamide, vitamin B6, L-lysine hydrochloride, pyrroloquinoline quinone and auxiliary materials. The astragalus mongholicus fermentation extract can improve the ATP generation efficiency, reduce lactic acid accumulation after exercise, relieve damage of oxidative stress to muscle and nerve cells and reduce immunosuppression caused by fatigue; the platycodon grandiflorum extract has the effects of refreshing mind and restoring consciousness, improving cognitive function decline caused by central fatigue, enhancing capillary permeability and promoting removal of metabolic wastes. The radix astragali fermentation extract and the radix platycodonis extract are compounded to achieve a synergistic effect, so that the composition has an excellent anti-fatigue effect. Under the combined action of all the components, fatigue is relieved, energy is rapidly supplemented, and physical strength is recovered.

The invention discloses a fluorescent probe as well as a preparation method and application thereof. The invention provides a series of fluorescent probes with novel structures, and the fluorescent probes take 2-(isoquinoline-1-yl) pyrrole boron difluoride as fluorophores, so that the fluorescence quantum yield of the probes is improved, the detection resolution of nitric oxide is increased, and the detection sensitivity is improved. The fluorescent probe disclosed by the invention has the characteristics of large Stokes displacement, high fluorescence quantum yield, good selectivity and short response time.

The invention relates to the technical field of separation and purification devices, in particular to a separation and purification device for 8-hydroxyquinoline crystallization. The device comprises a crystallization kettle used for cooling an 8-hydroxyquinoline solution, a stirring assembly is arranged in the crystallization kettle, the stirring assembly is provided with a plurality of cleaning assemblies in the radial direction of the crystallization kettle, each cleaning assembly comprises a scraping part and a pneumatic part, the scraping parts are slidably connected to the side, close to the inner wall of the crystallization kettle, of the stirring assembly, and the pneumatic parts are arranged on the scraping parts. The pneumatic part is used for pushing the scraping part to be close to the inner wall of the crystallization kettle; the increased air pressure in the pressure-bearing cavity pushes the pressure-bearing plate to slide towards one side close to the contraction groove, the telescopic arm is pushed out of the contraction groove through the sliding rod, and due to the fact that large air pressure is accumulated in the pressure-bearing cavity before the telescopic arm stretches out of the contraction groove, the conical part is inserted into the crystal above the liquid level at the moment that the top of the contraction groove is completely out of shielding of the installation groove. The telescopic arm instantly releases large force, and it can be ensured that the conical part is inserted into crystals tightly combined with the inner wall of the crystallization kettle.

The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.

The invention belongs to the technical field of microorganisms, and particularly relates to a denitrifying hyphomicrobium JCSS230201 strain and application of the denitrifying hyphomicrobium JCSS230201 strain in production of pyrroloquinoline quinone. The denitrifying hyphomicrobe JCSS230201 obtained through screening is a natural high-yield pyrroloquinoline quinone strain, pyrroloquinoline quinone can be efficiently produced in a culture medium only containing methanol and inorganic salt without a complex regulation and control process, experimental results show that the yield of pyrroloquinoline quinone reaches 1056.9 mg / L after fermentation is carried out for 182 h under the condition of the invention, and the yield of pyrroloquinoline quinone reaches 1056.9 mg / L. The natural strain is combined with a low-cost process, and a technical approach which is more economical, stable and easy for industrial preparation is provided for PQQ.

The invention discloses a health-care food for delaying ovarian aging, which belongs to the technical field of health-care foods and comprises a composition for improving the levels of anti-mullerian test tube hormone and superoxide dismutase and functional auxiliary materials, the composition for improving the anti-muller test tube hormone and superoxide dismutase level is prepared from the following components in parts by weight: 2 to 5 parts of pyrroloquinoline quinone PQQ, 30 to 80 parts of cranberry powder and 40 to 100 parts of an isoflavone extract, and the content of the pyrroloquinoline quinone PQQ is 2 to 5 parts, the content of the cranberry powder is 30 to 80 parts, and the content of the isoflavone extract is 40 to 100 parts. The pyrroloquinoline quinone PQQ, the cranberry powder and the isoflavone extract in a specific formula have the effect of synergistically improving the levels of anti-muller test tube hormone and superoxide dismutase, and the health food prepared from the pyrroloquinoline quinone PQQ, the cranberry powder and the isoflavone extract can improve sleep, improve urinary tract infection of middle-aged women, delay ovarian aging and the like.